Skip to main content

Table 4 Effect of interaction between serum lipid levels and genetic variants at 1p13 on the risk of MI expressed as Odds Ratio (OR) and 95%CI in the SHEEP

From: Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels

  

N

OR (95%CI)

 

N

OR (95%CI)

 

N

OR (95%CI)

Rs599839

ApoB ≥75th perc

617

2.27

Tot-chol ≥75th perc

611

1.72

LDL-chol ≥75th perc

1304

1.63

(1.86-2.77)

(1.40-2.10)

(1.32-2.01)

 

AG + GG vs AA

601

1.34

AG + GG vs AA

562

1.13

AG + GG vs AA

188

1.13

(1.10-1.64)

 

(0.93-1.37)

(0.94-1.37)

 

Both

234

1.76

Both

474

1.80

Both

474

1.68

(1.33-2.34)

(1.36-2.37)

(1.24-2.27)

S (95%CI)

  

0.47

  

0.94

  

0.89

(0.24-0.90)

(0.46-1.92)

(0.38-2.06)

Rs646776

ApoB ≥75th perc

536

2.18

Tot-chol ≥75th perc

582

1.79

LDL-chol ≥75th perc

416

1.54

(1.76-2.70)

(1.45-2.20)

(1.23-1.93)

 

CC + CT vs TT

787

1.09

CC + CT vs TT

751

0.98

CC + CT vs TT

837

0.94

(0.90-1.33)

(0.81-1.19)

(0.79-1.13)

 

Both

312

1.79

Both

350

1.76

Both

243

1.68

(1.38-2.32)

(1.37-2.25)

(1.27-2.23)

S (95%CI)

  

0.62

  

0.97

  

1.39

   

(0.34-1.12)

  

(0.50-1.89)

  

(0.53-3.63)

  1. The table provides the OR (95%CI) relative to the risk of MI associated with the exposure to high serum levels of ApoB, total-cholesterol (tot-chol), LDL-cholesterol (LDL-chol) in the absence of the allele G at rs599839 and of the allele C at rs646776 in the first row of the two sections; the risk associated with the exposure to the allele G or C in the absence of the exposure to high lipid serum levels in the second row of each section and the risk associated with the exposure to both serum levels and genotype in the third row of each section. The last row of each section reports the S index along with the 95%CI.